WO1999022720A3 - Selective cyclooxygenase-2 inhibitors against premature labor - Google Patents
Selective cyclooxygenase-2 inhibitors against premature labor Download PDFInfo
- Publication number
- WO1999022720A3 WO1999022720A3 PCT/US1998/022246 US9822246W WO9922720A3 WO 1999022720 A3 WO1999022720 A3 WO 1999022720A3 US 9822246 W US9822246 W US 9822246W WO 9922720 A3 WO9922720 A3 WO 9922720A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- selective cyclooxygenase
- premature labor
- inhibitors against
- against premature
- subject
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98955026A EP1027048A2 (en) | 1997-10-31 | 1998-10-27 | Selective cyclooxygenase-2 inhibitors against premature labor |
BR9813164-8A BR9813164A (en) | 1997-10-31 | 1998-10-27 | Method of using cyclooxygenase-2 inhibitors to maintain the fetal arterial duct during treatment and prevent premature labor pains |
CA002308639A CA2308639A1 (en) | 1997-10-31 | 1998-10-27 | Method of using cyclooxygenase-2 inhibitors in maintaining the fetal ductus ateriosus during treatment and prevention of preterm labor |
AU11926/99A AU758566B2 (en) | 1997-10-31 | 1998-10-27 | Method of using cyclooxygenase-2 inhibitors in maintaining the fetal ductus ateriosus during treatment and prevention of preterm labor |
JP2000518654A JP2001521889A (en) | 1997-10-31 | 1998-10-27 | Use of cyclooxygenase-2 inhibitors to maintain fetal arterial tract during treatment and prevention of preterm labor |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6388997P | 1997-10-31 | 1997-10-31 | |
US60/063,889 | 1997-10-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1999022720A2 WO1999022720A2 (en) | 1999-05-14 |
WO1999022720A3 true WO1999022720A3 (en) | 1999-08-26 |
Family
ID=22052179
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1998/022246 WO1999022720A2 (en) | 1997-10-31 | 1998-10-27 | Selective cyclooxygenase-2 inhibitors against premature labor |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1027048A2 (en) |
JP (1) | JP2001521889A (en) |
AR (1) | AR014000A1 (en) |
AU (1) | AU758566B2 (en) |
BR (1) | BR9813164A (en) |
CA (1) | CA2308639A1 (en) |
TW (2) | TW577739B (en) |
WO (1) | WO1999022720A2 (en) |
ZA (1) | ZA989876B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL152792A0 (en) * | 2000-06-08 | 2003-06-24 | Univ Texas | Heterocycle derivatives and methods of use |
ES2275218T3 (en) | 2003-05-07 | 2007-06-01 | Osteologix A/S | HYDROSOLUBLE STRONTIUM SALTS FOR THE TREATMENT OF CARTILAGOS AND / OR BONE AFFECTIONS. |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5521207A (en) * | 1993-11-30 | 1996-05-28 | G.D. Searle & Co. | Substituted pyrazolyl benzenesulfonamide for the treatment of inflammation |
US5677318A (en) * | 1996-07-11 | 1997-10-14 | Merck Frosst Canada, Inc. | Diphenyl-1,2-3-thiadiazoles as anti-inflammatory agents |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994026731A1 (en) * | 1993-05-13 | 1994-11-24 | Merck Frosst Canada Inc. | 2-substituted-3,4-diarylthiophene derivatives as inhibitors of cyclooxygenase |
US5474995A (en) * | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
EP0889724A1 (en) * | 1996-02-27 | 1999-01-13 | Rpms Technology Limited | Cox-2 selective inhibitors for managing labour and uterine contractions |
-
1998
- 1998-10-27 JP JP2000518654A patent/JP2001521889A/en not_active Withdrawn
- 1998-10-27 CA CA002308639A patent/CA2308639A1/en not_active Abandoned
- 1998-10-27 WO PCT/US1998/022246 patent/WO1999022720A2/en active IP Right Grant
- 1998-10-27 BR BR9813164-8A patent/BR9813164A/en not_active Application Discontinuation
- 1998-10-27 AU AU11926/99A patent/AU758566B2/en not_active Ceased
- 1998-10-27 EP EP98955026A patent/EP1027048A2/en not_active Ceased
- 1998-10-29 ZA ZA9809876A patent/ZA989876B/en unknown
- 1998-10-30 TW TW087118094A patent/TW577739B/en not_active IP Right Cessation
- 1998-10-30 TW TW092134686A patent/TW200404535A/en unknown
- 1998-10-30 AR ARP980105483A patent/AR014000A1/en not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5521207A (en) * | 1993-11-30 | 1996-05-28 | G.D. Searle & Co. | Substituted pyrazolyl benzenesulfonamide for the treatment of inflammation |
US5677318A (en) * | 1996-07-11 | 1997-10-14 | Merck Frosst Canada, Inc. | Diphenyl-1,2-3-thiadiazoles as anti-inflammatory agents |
Non-Patent Citations (7)
Title |
---|
BOTTING: "COX-2 : selective inhibitors in clinical trials", DRUG NEWS AND PERSPECTIVES, vol. 9, no. 2, 1996, pages 123 - 128, XP002104738 * |
DATABASE EMBASE ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL; XP002104739 * |
KATORI ET AL.: "Multiple roles of inducible cyclooxygenase-2 and its selective inhibitors", FOLIA PHARMACOLOGICA JAPONICA, vol. 109, no. 6, 1 June 1997 (1997-06-01), pages 247 - 258 * |
SMITH: "The pharmacology of the ductus arteriosus", PHARMACOL. REVIEWS, vol. 50, no. 1, 1 March 1998 (1998-03-01), pages 35 - 50, XP002104737 * |
VANE ET AL.: "Cyclooxygenases 1 and 2", ANN. REV. PHARMOCOL. TOXICOL., vol. 38, 1 January 1998 (1998-01-01), pages 97 - 120, XP002074177 * |
VANE ET AL.: "Mechanism of action of antiinflammatory drugs", INT. J. TISSUE REACT., vol. 20, no. 1, January 1998 (1998-01-01), pages 3 - 15, XP002104736 * |
VANE ET AL.: "Mechanism of action of aspirin-like drugs", SEMIN. ARTHRITIS RHEUM., vol. 26, no. 6sup1, June 1997 (1997-06-01), pages 2 - 10, XP002104735 * |
Also Published As
Publication number | Publication date |
---|---|
EP1027048A2 (en) | 2000-08-16 |
AR014000A1 (en) | 2001-01-31 |
AU1192699A (en) | 1999-05-24 |
AU758566B2 (en) | 2003-03-27 |
JP2001521889A (en) | 2001-11-13 |
CA2308639A1 (en) | 1999-05-14 |
WO1999022720A2 (en) | 1999-05-14 |
ZA989876B (en) | 1999-10-29 |
BR9813164A (en) | 2000-08-22 |
TW577739B (en) | 2004-03-01 |
TW200404535A (en) | 2004-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2267186A1 (en) | Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia | |
DK1023382T3 (en) | Composite propellant, composite filtration agents and processes for their preparation and use | |
WO1999004752A3 (en) | Methods for treating skin pigmentation | |
CA2258606A1 (en) | Crystal form ii of clarithromycin | |
EP1077063A3 (en) | Methods for treating skin pigmentation | |
CA2201123A1 (en) | Method of hair removal | |
EP0935963A3 (en) | The use of MMP-13 selective inhibitors for the treatment of osteoarthritis and other matrix metalloproteinase-mediated disorders | |
WO2002098444A3 (en) | Use of hepcidin for preparing a medicament for treating disorders of iron homeostasis | |
AU2001262723A1 (en) | 1,2-dihydropyridine compounds, process for preparation of the same and use thereof | |
DK1066056T4 (en) | Iron dextran compound for use as a component of a therapeutic agent for the prevention or treatment of iron deficiency, method of preparing the iron dextran compound and use of this compound for the manufacture of an ... | |
EP0690044A3 (en) | Process for producing amidoether carboxylic acid or salt thereof, and surface active agent mixture containing the same | |
WO2002034201A3 (en) | Use of pericyte apoptosis inhibitors for treating and/or preventing diabetic retinopathy | |
WO1998036730A3 (en) | Compositions for treating acne rosacea | |
WO2002028434A3 (en) | Use of a ppar delta activator for treating inflammatory conditions | |
EP1249240A4 (en) | Inhibitors against sodium ion absorption, and preventive or therapeutic agents and foods containing the same | |
AU2825295A (en) | Method for the treatment, prevention or minimization of hair loss | |
EP1051169A4 (en) | Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases | |
MXPA03004303A (en) | Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain. | |
EP0943311A3 (en) | Method of inhibiting hair growth | |
WO1999022720A3 (en) | Selective cyclooxygenase-2 inhibitors against premature labor | |
WO2001041709A3 (en) | Methods for treating cell death diseases and inflammation | |
AU6502194A (en) | Oestriol-containing hormonal agent for the prophylaxis and treatment of arterial conditions in humans, method of preparing it and its use | |
WO2005042718A3 (en) | Compositions and methods for treating, preventing, reversing and inhibiting pain | |
WO1999066780A3 (en) | Cinoxacin lanthanide chelates and their use as biomolecular probes | |
AU5868699A (en) | Novel therapeutic use of compounds with beta-3-agonist activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11926/99 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2308639 Country of ref document: CA Ref document number: 2308639 Country of ref document: CA Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2000 518654 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1998955026 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/A/2000/004204 Country of ref document: MX |
|
NENP | Non-entry into the national phase |
Ref country code: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 1998955026 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWG | Wipo information: grant in national office |
Ref document number: 11926/99 Country of ref document: AU |